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Elevated preoperative heart rate is associated with perioperative myocardial injury and death. 
In apparently healthy individuals, high resting heart rate is associated with development of 
cardiac failure. Since patients with overt cardiac failure have poor perioperative outcomes, 
we hypothesised that subclinical cardiac failure, identified by cardiopulmonary exercise 
testing, was associated with elevated preoperative heart rate >87 beats.min-1 (HR>87). 
 
Methods 
Secondary analysis of an observational cohort study of surgical patients aged ≥45 years. The 
exposure of interest was HR>87, recorded at rest before preoperative cardiopulmonary 
exercise testing. The pre-defined outcome measures were established predictors of mortality 
in patients with overt cardiac failure in the general population: E/ CO2 ratio ≥34, heart rate 
recovery ≤6 and peak O2 ≤14 ml.kg-1min-1. We used logistic regression analysis to test for 
association between HR>87 and markers of cardiac failure. We also examined the 
relationship between HR>87 and preoperative left ventricular stroke volume in a separate 
cohort of patients. 
 
Results  
HR>87 was present in 399/1250 (32%) patients: 438/1250 (35%) had E/ CO2 ratio ≥34, 
200/1250 (16%) had heart rate recovery ≤6 and 396/1250 (32%) had peak O2 ≤14ml.kg-
1min-1. HR>87 was independently associated with peak O2 ≤14ml.kg-1min-1 [odds ratio 
(OR):1.69 [1.12-3.55]; p=0.01] and heart rate recovery ≤6 (OR:2.02 [1.30-3.14]; p<0.01). 
However, HR>87 was not associated with E/ CO2 ratio ≥34 (OR:1.31 [0.92-1.87]; p=0.14). 









volume (OR:3.21 [1.26-8.20]; p=0.01).  
 
Conclusions 
Elevated preoperative heart rate is associated with impaired cardiopulmonary performance 








Over 1.5 million major surgical procedures are carried out in the United Kingdom each year 
and one in six patients will experience a complication after surgery.1, 2 One in ten patients 
will sustain myocardial injury after non-cardiac surgery, which is strongly associated with 
mortality.3 However, the presence of coronary artery disease is a poor predictor of morbidity 
and mortality in these patients.4 In contrast, elevated preoperative resting heart rate (>87 
beats.min-1) is independently associated with myocardial injury and mortality.5  Although 
tachycardia may be attributable to acute pathophysiology (e.g. sepsis, systemic 
inflammation), mechanisms to explain this association remain unclear.6 Tachycardia may 
promote myocardial injury through oxygen supply-demand imbalance.7 However, since 
treatment with beta-blockers or clonidine fail to reduce the incidence of myocardial injury, 
other pathophysiological mechanisms are likely to be involved.8, 9  
Patients with a confirmed diagnosis of cardiac failure syndrome are at very high risk 
of perioperative mortality.10, 11 Cardiopulmonary exercise testing can identify 
cardiopulmonary and/or autonomic dysfunction, and has been used for prognostication in 
patients with confirmed cardiac failure and for risk assessment before surgery.12-14 In the 
general population, elevated resting heart rate is an independent risk factor for the 
development of heart failure.4, 15, 16 Therefore, elevated preoperative heart rate may indicate 
underlying sub-clinical cardiac impairment; thus generating several plausible - and 
potentially novel - pathophysiological mechanisms that may contribute to perioperative 
myocardial injury, morbidity and mortality.5, 7, 17, 18   
We hypothesised that elevated preoperative resting heart rate (>87 beats.min-1)5 was 
associated with impaired cardiovascular and/or autonomic function consistent with sub-
clinical cardiac failure.  We tested this hypothesis by evaluating cardiovascular and 
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autonomic factors derived from preoperative cardiopulmonary exercise testing that are known 







Study design  
This was a secondary analysis of data obtained prospectively from the Perioperative 
Morbidity – Heart Rate (POM-HR) study, a multi-centre observational cohort study of high-
risk patients undergoing non-cardiac surgery. The methods have been published previously.19 
The study was approved by the NRES Committee London (Camden & Islington; 
MREC:12/LO/0453) and registered with Controlled Trials (ISRCTN88456378).  
 
Patient population 
Patients were eligible for inclusion if they were aged 45 years or more, were scheduled for 
major surgery predicted to last for more than two hours, and were referred for 
cardiopulmonary exercise testing (CPET) as part of their routine preoperative assessment. 
Patients provided written informed consent before taking part in the study (prior to exercise 
testing). The exclusion criteria were refusal of consent or contraindications to CPET. These 
criteria are very similar to the eligibility criteria for the VISION study.3 
 
Data collection 
In POM-HR before surgery, patient age, gender, operative time, established measures of 
preoperative risk (including diabetes mellitus, cardiac and cerebrovascular disease) and 
haemoglobin were recorded. All participants underwent preoperative cardiopulmonary 
exercise testing (CPET).  
 
Outcome measures 
The primary outcomes measures were three cardiopulmonary exercise test (CPET) derived 
variables that are established and independent predictors of mortality in patients with cardiac 
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failure: ventilatory equivalent for carbon dioxide ( E/ CO2) ≥34, heart rate recovery ≤6 and 
peak oxygen consumption ( O2) ≤14 ml.kg-1min-1.12 Secondary outcome measures were other 
CPET-derived cardiopulmonary and autonomic variables known to be associated with 
postoperative clinical outcomes or cardiovascular morbidity in the general population: 
preoperative pulse pressure, oxygen consumption at the anaerobic threshold, peak oxygen 
pulse, peak heart rate and heart rate reserve. Full details for the original papers detailing the 
prognostic value of these variables is provided in supplementary table 1. 
 
Cardiopulmonary exercise testing (CPET) 
CPET was carried out at each participating hospital in designated CPET laboratories. Prior to 
CPET, participants were instructed to continue their normal medications up to, and including, 
the day of the test. CPET was conducted using a standard incremental ramp protocol to 
maximal exercise tolerance using an electromagnetically braked cycle ergometer. Equipment 
was calibrated before each test, including calibration of the gas-analyser using standard 
reference gases. During CPET continuous 12-lead electrocardiography (heart rate), 
intermittent sphygmomanometry (arterial blood pressure) and breath-by-breath measurement 
of gas exchange were performed. Before each test, arterial blood pressure and heart rate were 
measured in the sitting position after at least 30 seconds rest. Participants were instructed to 
continue cycling as the ramp (watts) increased, until they were unable to continue due to 
symptom-limited fatigue. After reaching peak exercise tolerance, continued physiological 
measurements were recorded during the period of recovery from exercise.  
The anaerobic threshold (AT) was determined by two independent assessors 
according to published guidelines using the modified V-slope method and confirmed by 
ventilatory equivalents for oxygen ( E/ O2) and carbon dioxide ( E/ CO2). Oxygen 
consumption (ml.kg-1min-1) was measured at the anaerobic threshold and at peak exertion. 
V! V!
V!
V! V! V! V!
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The ventilatory equivalent for carbon dioxide ( E/ CO2) was measured at the anaerobic 
threshold and presented as a ratio. Resting heart rate was defined as heart rate measured 
before each test after 30 seconds in the sitting position. Peak heart rate, which reflects 
sympathetic activation, was defined as maximal heart rate achieved during exercise. Heart 
rate recovery, a measure of parasympathetic activity, was calculated as the difference 
between peak heart rate and heart rate one minute after the end of peak exercise, thus 
representing the change in heart rate during the one minute after exercise in beats.minute-1. 
Peak oxygen pulse (ml.beat-1), a surrogate marker for cardiac stroke volume,20 was calculated 
as peak oxygen consumption (ml.min-1) divided by peak heart rate (beats.min-1). 
 
Statistical analysis 
We used STATA version 14 (StataCorp LP, Texas, USA) to analyse the data. Categorical 
data were summarised as number with percentage. Continuous data with a Normal 
distribution were summarised as mean with standard deviation; continuous data that do not 
follow a Normal distribution were summarised as median with interquartile range.  
We dichotomised the sample according to heart rate >87 beats.min-1 and summarised 
descriptive physiological variables for each group.5 We used a t-test to identify differences in 
continuous data between groups and chi-squared test to identify differences in categorical 
data between groups. We used logistic regression analysis to test for association between 
elevated preoperative heart rate > 87 beats.minute-1 and each outcome measure, first using 
univariable analysis. In addition, we tested whether pre-existing cardiovascular medication 
(beta-blockers, calcium channel antagonists, diuretics, nitrates, anti-platelet agents, statins or 
angiotensin converting enzyme inhibitors/receptor blockers) were associated with heart rate 
>87 beats.min-1.  We subsequently used multivariable analysis to correct for potential 




Revised Cardiac Risk Index (RCRI) >2.3, 21 We chose to include RCRI as this is routinely 
used as a risk score to predict MINS and as a comparator with new risk stratification 
modalities (e.g. preoperative coronary computed tomographic angiography).3 The results of 
logistic regression analyses were presented as odds ratios with 95% confidence intervals. 
P≤0.05 was considered statistically significant. 
 
Preoperative left ventricular stroke volume and autonomic analyses 
We undertook a post-hoc analysis of data from the OPTIMISE and POM-O trials (ISRCTN: 
76894700 and 04386758, respectively), the principle findings and methods of which have 
been published elsewhere.18, 22 We tested the hypothesis that preoperative resting heart rate 
>87 beats.min-1 was associated with a cardiac failure phenotype by assessing preoperative left 
ventricular stroke volume and autonomic measures in patients undergoing major abdominal 
surgery. We restricted our analysis to haemodynamic data collected from cardiac output 
monitors before and during surgery, which provided detailed beat-by-beat measurements of 
heart rate, cardiac output and stroke volume. We dichotomised the cohort according to a 
mean preoperative heart rate threshold of >87 beats.min-1 and compared mean beat-by-beat 
preoperative left ventricular stroke volume between groups using a t-test. We used logistic 
regression analysis to test for association between mean preoperative heart rate >87 
beats.min-1 and impaired preoperative stroke volume <57ml, defined according to previous 
research in patients with heart failure, corrected for age >75 years, gender and history of 
ischaemic heart disease.23 
We also assessed the relative contributions of sympathetic/parasympathetic 
modulation of preoperative heart rate >87 in the POM-O cohort by analysing time and 
frequency-domain measures in accordance with ACC/AHA Task Force guidelines	as reported 
previously.24, 25 Parasympathetic cardiac activity was assessed using two time-domain 
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measures: Root Mean Square of the Successive Differences	 (RMSSD) and pNN50, which 
reports the proportion of consecutive NN intervals that differ by more than 50ms. In addition, 
the high frequency component of heart rate power spectral analysis was quantified. The low 
frequency/High Frequency ratio was calculated to assess sympathetic-parasympathetic 








1,572 surgical patients underwent CPET at one of five participating United Kingdom 
hospitals. We excluded cases that were missing complete CPET data or pre-defined 
covariates, leaving 1,250 patients for the final analysis (Supplementary Figure 1). Patient 
characteristics are presented in table 1. Resting preoperative heart rate >87 beats min-1 was 
recorded in 399/1250 (31.9%) patients. Age, body mass index, cardiovascular risk factors (as 
defined by Revised Cardiac Risk Index) and resting systolic blood pressure were similar for 
patients with heart rate >87 beats.min-1 compared to those with HR≤87 beats.min-1 (table 1). 
52/1250 (4.2%) patients had an established diagnosis of heart failure and 162/1250 (13.0%) 
had a diagnosis of ischaemic heart disease. Patients with resting HR>87 beats.min-1 had 
elevated heart rates recorded immediately before surgery, the time point at which the VISION 
study recorded preoperative variables.3 
 
Primary analysis 
Of 1250 patients 438 (35%) had E/ CO2 ratio ≥34, 200 (16%) had heart rate recovery ≤6 
and 396 (32%) had peak O2 ≤14 ml.kg-1min-1. The results of the logistic regression analyses 
for heart rate > 87 beats.minute-1 against the primary outcome measures are shown in table 2. 
After correcting for potential confounding factors heart rate >87 beats.minute-1 was 
associated with peak O2 ≤14 ml.kg-1min-1 (odds ratio (OR) 1.69 [1.12-3.55]; p=0.01) and 
heart rate recovery ≤6 (OR 2.02 [1.30-3.14]; p<0.01). However, heart rate >87 beats.minute-1 
was not associated with E/ CO2 ratio ≥34 (OR 1.31 [0.92-1.87]; p=0.14).  
 
Secondary analysis 
Patients with resting heart rate >87 beats.minute-1 had lower peak oxygen consumption, 








pulse, a robust measure of left ventricular stroke volume, was lower in patients with resting 
heart rate >87 beats.minute-1 beats.min-1.20 Resting heart rate >87 beats.min-1 was not 
associated with oxygen consumption at the anaerobic threshold <11.1ml.kg.min-1 (OR 1.24 
[0.98-1.59]; p=0.08) using univariable logistic regression analysis. However, resting heart 
rate >87 beats.min-1 was associated with peak oxygen pulse <12ml.beat-1 (OR 2.80 [2.19-
3.58]; p<0.01)) using univariable logistic regression analysis. Patients with heart rate ≤87 
beats.min-1 had near normal predicted oxygen pulse, when expressed as a percentage of 
population-specific normal values (94.9% (95%CI: 93.0-96.9). By contrast, percentage 
predicted peak oxygen pulse was 15.2% (95%CI: 12.3-18.1) lower in patients with resting 
heart rate >87 beats.min-1 (p<0.01).  Patients with resting heart rate >87 beats.min-1 exhibited 
higher peak heart rates during CPET. Heart rate recovery, the longer duration of which 
reflects impaired parasympathetic reactivation following cessation of peak exercise, was 
prolonged in patients with resting heart rate >87 beats.min-1.  
 
Sensitivity analysis 
In patients with heart failure the prognostic threshold for peak oxygen consumption is lower 
(≤12ml.kg.min-1) in patients receiving beta-blockers. We performed a sensitivity analysis by 
repeating the primary univariable logistic regression using the lower threshold in patients 
taking beta-blockers (247/1250). However, we did not identify association between impaired 
oxygen consumption and HR>87 (OR 1.37 [0.63-2.96]; p=0.43).  
 
Preoperative left ventricular stroke volume and perioperative autonomic function 
We further examined cardiac and autonomic function in a separate cohort of patients. 181 
patients with mean age 68 years (SD 9) that underwent major surgery in the OPTIMISE and 
POM-O trials had complete beat-by-beat cardiac output monitor data available for analysis 
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(supplementary figure 2). From both trials, patients with preoperative heart rate >87 
beats.min-1 had lower mean preoperative stroke volume (mean difference 23.5 [8.0-38.9] ml; 
p=0.03). Preoperative heart rate >87 beats.min-1 was associated with impaired preoperative 
stroke volume <59ml (OR 3.21 [1.26-8.20]; p=0.01), taking into account patients with an 
established preoperative diagnosis of heart failure (supplementary table 2). We also 
performed a detailed analysis of autonomic data captured in the POM-O cohort, to delineate 
the components of preoperative tachycardia. Heart rate was higher throughout the 
intraoperative period in patients with preoperative heart rate >87 beats.min-1 (Figure 1). 
Preoperative heart rate >87 beats.min-1 was chiefly associated with measures indicative of 
lower parasympathetic activity (Figure 1b-d). This was accompanied by similar sympathetic 
activity (LF) between groups (not shown), but higher LF/HF ratio (Figure 1e), reflecting 
dominant sympathetic autonomic modulation of heart rate in patients with heart rate >87 
beats.min-1 due to loss of cardiac vagal tone. Spontaneous baroreflex sensitivity (Figure 1f) 
was also lower in patients with preoperative heart rate >87 beats.min-1. Higher lactate was 
observed at the end of surgery in patients with preoperative heart rate >87 beats.min-1 (OR of 






The principal finding of this generalizable, multi-centre cohort study is that resting 
preoperative heart rate >87 beats.minute-1 is associated with marked cardiorespiratory and 
autonomic impairment, compatible with the pathophysiological hallmarks of significant - yet 
sub-clinical - cardiac failure. These findings are reinforced by interrogation of perioperative 
haemodynamic data from the OPTIMISE and POM-O trials. In this cohort, elevated 
preoperative heart rate >87 beats.minute-1 is common and cannot be accounted for by acute 
pathophysiology causing relative tachycardia (e.g. sepsis, systemic inflammation).6 Taken 
together, this ‘reverse-translational’ approach provides a physiological framework affording 
further insight into why elevated resting heart rate is independently associated with 
perioperative myocardial injury and excess mortality.3 Our results show that elevated resting 
heart rate is associated with several features of impaired cardiorespiratory and autonomic 
function indicative of sub-clinical cardiac failure. This is consistent with previous reports 
confirming that patients with an established diagnosis of cardiac failure preoperatively have 
substantially higher morbidity and mortality after non-cardiac surgery.10 
Resting heart rate is progressively associated with increasing risk of incident heart 
failure in otherwise apparently healthy men and women.15, 16 Experimental data show that 
sustained elevated heart rate induces cardiac failure in the absence of structural or 
atherosclerotic heart disease.26 However, elevated heart rate does also appear to increase the 
risk of heart failure in individuals with established hypertension, coronary heart disease and 
valvular heart disease.27 The EPIC-Norfolk study showed that a 10 beats.minute-1 increase in 
resting heart rate was independently associated with an 11% increase in risk of developing 
cardiac failure.15 The 15 year Rotterdam Study of 4768 apparently healthy individuals, with a 
similar age to our cohort, showed that incremental increases of 10 beats.min-1 in men was 
associated with the development heart failure within 6 months of study enrolment.16 Thus, 
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elevated resting heart rate is an independent risk factor for the development of heart failure in 
healthy older men in the general population, mirroring the gender imbalance evident in 
VISION, where male gender was an independent risk factor for MINS/mortality. The 
Rotterdam cohort study also established that the reproducibility of the association between 
heart rate and development of heart failure was not influenced by the measurement method of 
heart rate, as we also found in our study where heart rate was similar before CPET and 
immediately preoperatively.16  
 Several mechanisms may mechanistically link resting heart rate, incident heart failure 
and perioperative myocardial injury. A causal link between elevated heart rate, myocardial 
oxygen demand, coronary blood flow and myocardial injury has long been postulated, chiefly 
through myocardial oxygen supply/demand imbalance. However, our study also identifies 
alternative pathological explanations for the development of MINS/perioperative mortality. 
At peak exercise, oxygen pulse is a robust surrogate measure of left ventricular stroke 
volume.20 Notably, the oxygen pulse measurements in patients with HR >87 beats.minute-1 
were similar to patients with mild-to-moderate heart failure.22 This is compatible with the 
hypothesis that heart rate is increased as result of lower stroke volume, in order to maintain 
cardiac output- a relationship that is also observed consistently in patients with heart failure. 
This hypothesis is further supported by the observed relationship between elevated heart rate 
and reduced oxygen consumption, which is independent of age, gender and heart disease in 
medical patients.28 Low stroke volume, and hence oxygen delivery, may be exacerbated by 
anaesthesia, leading to intraoperative hypotension and associated end-organ hypoperfusion - 
including myocardial and renal injury.29 
Autonomic impairment is also mechanistically linked with preoperative cardiac 
ischaemia and postoperative morbidity following non-cardiac surgery. Sympathetic and 
parasympathetic components may independently contribute to MINS. Reduction in heart rate 
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after peak exercise -heart rate recovery - is due to parasympathetic reactivation during the 
first few minutes of recovery.30 Reduced cardiac vagal activity promotes cardiac injury 
through the loss of cardioprotective mechanisms, including rate control and metabolic 
reprogramming.7, 31 Patients with relatively increased sympathetic activity, as manifest by 
higher resting heart rate, are more likely to receive sympatholytic medication. In the context 
of our findings, the use of clonidine and/or beta-blockade in these patients may precipitate 
hypotension given that higher heart rate is associated with impaired stroke volume/cardiac 
contractility.  
 Strengths of this study include the observation that resting heart rate was comparable 
both before CPET and on the day of surgery. The ‘reverse translational’ approach, using 
observations from the VISION study to plan detailed physiological assessment using two 
independent approaches in a substantial number of patients, suggests these data are 
generalizable. Although increasing chronological age is associated with declining 
cardiopulmonary and autonomic function, multivariable logistic analysis found that the 
association between elevated heart rate and impaired cardiorespiratory performance was 
independent of age.32, 33 Significant weaknesses include the observational design, which 
cannot, by definition, establish causality. However, we considered potential confounding 
factors by adjusting for various established clinical risk factors and cardiovascular drug 
therapy, for example beta-blockers, which are know to affect heart rate. Heart rate is 
mathematically coupled with some CPET variables: in particular, oxygen pulse at peak is 
derived by dividing peak oxygen consumption by contemporaneous HR – so if HR is high 
then oxygen pulse will, by definition, be decreased.  However, it is notable that we have 
shown an association rather between raised HR prior to CPET decreased oxygen pulse at 
peak. Moreover, an association between pre CPET HR>87 and unfavourable CPET measures 
was also apparent for O2 and E/ O2 at AT, variables which are not mathematically V! V! V!
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coupled to heart rate. A lack of data on intraoperative vasopressor use, other than 
norepinephrine, is likely to underestimate the extent and/or effect of clinically relevant 
hypotension on clinical outcomes and intraoperative haemodynamic measures. Our results 
may be confounded by factors that were not measured, for example we are unaware of the 
incidence of obstructive sleep apnoea in this sample, which is known to be associated with 
autonomic impairment.34, 35 
In summary, elevated preoperative heart rate is associated with cardiopulmonary and 
autonomic impairment indicative of subclinical heart failure. Perioperative myocardial injury, 
might be, at least partially, explained by subclinical cardiac failure. Further research targeting 
abnormal cardiovascular and autonomic phenotypes may improve clinical outcomes, 
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Figure 1. Elevated heart rate and autonomic measures from post-hoc analysis of the 
POM-O cohort. The analysis included data from 187 patients recruited from the POM-O 
trial. A. Resting mean (95%CI) heart rate (HR) before surgery, stratified by heart rate >87 
beats.min-1. B. Mean (95%CI) Root Mean Square of the Successive Differences	(RMSSD), a 
time-domain measure of parasympathetic modulation of heart rate. C. Mean (95%CI) pNN50, 
an additional time-domain measure of parasympathetic modulation of heart rate that reports 
the fraction of consecutive NN intervals that differ by more than 50ms. D. Median (IQR) 
preoperative values for high frequency (parasympathetic) component of heart rate power 
spectral analysis. E. Median (IQR) preoperative values for LF/HF ratio, a higher value for 
which indicates dominant sympathetic modulation of heart rate. F. Spontaneous baroreflex 
sensitivity (mean (95%CI)) G. Venous lactate measurements (mean (95%CI)) at the end of 
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Table 1. Baseline patient characteristics. Descriptive data stratified by resting heart rate 
>87 beats.minute-1, presented as frequencies with percentages (%) or mean (standard 
deviation; SD). Heart rate (HR) data in >87 beats.minute-1, blood pressure data in millimetres 
of mercury (mmHg). Other units as indicated. Hypothesis testing using t-test for continuous 
data and chi-squared test for categorical data. 
 
Characteristic HR >87 HR ≤87 
bpm 
p-value 
Number of patients 399 851 - 
Age (SD) 66.8 (10.0) 68.5 (9.6) <0.01 
Female gender (%) 139 (34.8) 231 (27.1) <0.01 
Body Mass Index (SD) 27.7 (5.6) 27.4 (4.9) 0.33 
Diabetes mellitus (%) 69 (17.3) 111 (13.0) 0.05 
Revised Cardiac Risk Index  
  
<0.01 
1 170 (42.6) 296 (34.8) - 
2 204 (51.1) 433 (50.8) - 
3 21 (5.2) 101 (12.3) - 
4 4 (1.0) 19 (4.8) - 
Type of surgery (%) 
  
<0.01 
Colorectal 133 (34.5) 283 (34.3) - 
Upper gastrointestinal 70 (18.1) 115 (14.0) - 
Vascular  33 (8.5) 126 (15.3) - 
Urology 74 (19.2) 186 (22.6) - 
Hepatobilliary 25 (6.5) 53 (6.4) - 
Maxillofacial 26 (6.7) 38 (4.6) - 
Gynaecological 9 (2.3) 1 (0.1) - 
Other 16 (4.1) 22 (2.7) - 
Preoperative medication (%) 
  
 
Beta-blocker 38 (9.5) 208 (24.7) <0.01 
Calcium channel anatagonist  65 (30.4) 107 (22.2) 0.02 
Diuretic 31 (14.5) 63 (13.1) 0.62 
Nitrate 13 (3.3) 50 (5.9) 0.05 
Anti-platelet 52 (24.3) 166 (34.5) 0.07 
Statin 77 (19.3) 199 (23.5) 0.09 
ACE inhibitor/ Angiotensin receptor 
blocker 
119 (30.0) 246 (29.1) 0.75 




Table 2. Logistic regression analysis. Univariable (unadjusted) analysis and multivariable 
analysis including variables significantly associated with the outcome measure in univariable 
analysis and age >75 years, male gender and Revised Cardiac Risk Index (RCRI) >2. The 
dependent variable was heart rate >87 beats.minute-1. Results presented as odds ratios with 
95% confidence intervals, with p-value. Angiotensin Converting Enzyme Inhibitor (ACE-I), 
Angiotensin Receptor Blocker (ARB). 
 
Univariable analysis Multivariable analysis 
Characteristic Odds ratio p-value Odds ratio p-value 
Age >75 years 0.78 (0.59-1.04) 0.09 0.87 (0.59-1.28) 0.48 
Male gender 0.70 (0.54-0.90) <0.01 0.79 (0.54-1.16) 0.23 
Revised Cardiac Risk Index >2 0.41 (0.26-0.64) <0.01 0.56 (0.30-1.03) 0.06 
Peak oxygen consumption ≤14 ml.kg.minute-1 1.39 (1.08-1.78) 0.01 1.69 (1.12-3.55) 0.01 
VE/VCO2 at anaerobic threshold ≥34 1.59 (1.24-2.03) <0.01 1.31 (0.92-1.87) 0.14 
Heart rate recovery ≤6 beats.minute-1 1.96 (1.44-2.67) <0.01 2.02 (1.30-3.14) <0.01 
Preoperative medications     
Beta-blocker 0.32 (0.22-0.47) <0.01 0.37 (0.22-0.61) <0.01 
Calcium channel antagonist  1.52 (1.06-2.19) 0.02 1.71 (1.15-2.55) <0.01 
Diuretic 1.12 (0.71-1.79) 0.62 - - 
Nitrate 0.54 (0.29-1.00) 0.05 0.37 (0.12-1.17) 0.09 
Anti-platelet 0.61 (0.42-0.88) <0.01 0.75 (0.49-1.15) 0.19 
Statin 0.78 (0.58-1.04) 0.10 - - 
ACE-I/ARB 1.04 (0.80-1.36) 0.75 - - 





Table 3. Physiological and cardiopulmonary exercise test variables. Data stratified by 
resting heart rate >87 beats.minute-1, presented as frequencies with percentages (%) or means 
with standard deviations (SD). Hypothesis testing with t-test for continuous data and chi-
squared test for categorical data. Heart rate (HR) data in >87 beats.minute-1, blood pressure 
data in millimetres of mercury (mmHg), rounded to the nearest whole number. Other units 
are shown. 
 





Preoperative haemodynamic variables 
   Resting heart rate (beats.min-1) 99 (10) 73 (10) <0.01 
Systolic blood pressure (mmHg) 147 (23) 145 (23) 0.23 
Diastolic blood pressure (mmHg) 84 (12) 81 (13) <0.01 
Pulse pressure (mmHg) 62 (20) 65 (19) 0.09 
Mean arterial pressure (mmHg) 104 (14) 101 (15) <0.01 
Preoperative CPET variables 





Peak oxygen consumption (ml.kg.min-1) 16.8 (4.8) 17.6 
(5.1) 
<0.01 
VE/VCO2 at anaerobic threshold 32.7 (5.7) 31.1 
(5.9) 
<0.01 
Peak oxygen pulse (ml.beat-1) 11.6 (2.9) 13.8 
(3.5) 
<0.01 
Peak heart rate (beats.min-1) 145 (19) 128 (23) <0.01 





Heart rate recovery (beats.min-1) 13 (15) 18 (13) <0.01 
        
 
